Credit: PROFESSOR JOHN ZAJICEK/Science Source
And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.
The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.
Walk with us.
Region- and lineage-specific transcriptomic changes appear to be responsible for the characteristic pathobiology of multiple sclerosis (MS).
A study that used single-nucleus RNA sequencing to assess changes in cell lineages in MS lesions has shed light on the selective cortical neuron damage and glial activation that contribute to the progression of MS lesions.
Multiple sclerosis patients who are young, male and have mild disability are more likely to be employed, based on a recent analysis of multiple sclerosis registries across North America, Germany, and the United Kingdom.
Sheila DeMelle was diagnosed at age 17 with multiple sclerosis. For most of her life, her MS didn’t slow her down too much. “My disability was invisible. I knew I had it; I knew the symptoms,” but her symptoms weren’t readily apparent.
Nearly one in five patients with a diagnosis of multiple sclerosis (MS) was found to be misdiagnosed upon further evaluation at specialized academic centers, according to a retrospective study published in Multiple Sclerosis and Related Disorders